Barboni Piero, Amore Giulia, Cascavilla Maria Lucia, Battista Marco, Frontino Giulio, Romagnoli Martina, Caporali Leonardo, Baldoli Cristina, Gramegna Laura Ludovica, Sessagesimi Elisa, Bonfanti Riccardo, Romagnoli Andrea, Scotti Roberta, Brambati Maria, Carbonelli Michele, Starace Vincenzo, Fiorini Claudio, Panebianco Roberta, Parisi Vincenzo, Tonon Caterina, Bandello Francesco, Carelli Valerio, La Morgia Chiara
From the Department of Ophthalmology (P.B., M.L.C., M.Ba., M.Br., V.S., F.B.), University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy; Studio Oculistico d'Azeglio (P.B.), Bologna, Italy.
Dipartimento di Scienze Biomediche e Neuromotorie (G.A., L.L.G., E.S., M.C., C.T., V.C.), Università di Bologna, Bologna, Italy.
Am J Ophthalmol. 2022 Sep;241:206-216. doi: 10.1016/j.ajo.2022.03.019. Epub 2022 Apr 20.
To describe the clinical phenotype of a cohort of patients with Wolfram syndrome (WS), focusing on the pattern of optic atrophy correlated with brain magnetic resonance imaging (MRI) measurements, as compared with patients with OPA1-related dominant optic atrophy (DOA).
Retrospective, comparative cohort study.
We reviewed 25 patients with WS and 33 age-matched patients affected by OPA1-related DOA. Ophthalmologic, neurologic, endocrinologic, and MRI data from patients with WS were retrospectively retrieved. Ophthalmologic data were compared with data from patients with OPA1-related DOA and further analyzed for age dependency dividing patients in age quartiles. In a subgroup of patients with WS, we correlated the structural damage assessed by optical coherence tomography (OCT) with brain MRI morphologic measurements. Visual acuity (VA), visual field mean defect (MD), retinal nerve fiber layer (RNFL), and ganglion cell layer (GCL) thickness were assessed by OCT and MRI morphologic measurements of anterior and posterior visual pathways.
Optic atrophy was present in 100% of patients with WS. VA, MD, and RNFL thickness loss were worse in patients with WS with a faster decline since early age as compared with patients with DOA, who displayed a more stable visual function over the years. Conversely, GCL sectors were overall thinner in patients with DOA since early age compared to patients with WS, in which GCL thickness started to decline later in life. The neuroradiologic subanalysis on 11 patients with WS exhibited bilateral thinning of the anterior optic pathway, especially the prechiasmatic optic nerves and optic tracts. Optic tract thinning was significantly correlated with GCL thickness but not with RNFL parameters.
Our results showed a generally more severe and diffuse degeneration of both anterior and posterior visual pathways in patients with WS, with fast deterioration of visual function and structural OCT parameters since early age. The pattern observed with OCT suggests that retinal ganglion cell axonal degeneration (ie, RNFL) precedes cellular body atrophy (ie, GCL) by about a decade. This differs substantially from DOA, in which a more stable visual function is evident with predominant early loss of GCL, indirectly supporting the lack of a primary mitochondrial dysfunction in patients with WS.
描述一组沃夫勒姆综合征(WS)患者的临床表型,重点关注与脑磁共振成像(MRI)测量结果相关的视神经萎缩模式,并与OPA1相关的显性视神经萎缩(DOA)患者进行比较。
回顾性比较队列研究。
我们回顾了25例WS患者和33例年龄匹配的受OPA1相关DOA影响的患者。回顾性收集WS患者的眼科、神经科、内分泌科和MRI数据。将眼科数据与OPA1相关DOA患者的数据进行比较,并进一步按年龄四分位数将患者分为不同年龄组进行年龄依赖性分析。在一组WS患者中,我们将光学相干断层扫描(OCT)评估的结构损伤与脑MRI形态学测量结果相关联。通过OCT评估视力(VA)、视野平均缺损(MD)、视网膜神经纤维层(RNFL)和神经节细胞层(GCL)厚度,并通过MRI对视觉通路的前后部进行形态学测量。
100%的WS患者存在视神经萎缩。与DOA患者相比,WS患者的VA、MD和RNFL厚度损失更严重,且自幼年起下降速度更快,而DOA患者多年来视觉功能更稳定。相反,与WS患者相比,DOA患者自幼年起GCL各扇形区总体更薄,WS患者的GCL厚度在生命后期才开始下降。对11例WS患者的神经放射学亚分析显示,前部视觉通路双侧变薄,尤其是视交叉前视神经和视束。视束变薄与GCL厚度显著相关,但与RNFL参数无关。
我们的结果表明,WS患者的前后视觉通路通常存在更严重和弥漫性的变性,自幼年起视觉功能和OCT结构参数迅速恶化。OCT观察到的模式表明,视网膜神经节细胞轴突变性(即RNFL)比细胞体萎缩(即GCL)早约十年。这与DOA有很大不同,DOA患者的视觉功能更稳定,主要表现为早期GCL缺失,间接支持WS患者不存在原发性线粒体功能障碍。